The finding of elevated CXCR4 in the AYA group echoes reports implicating CXCR4 in tumor invasiveness, suggesting it may also be a promising therapeutic target for intervention in papillary thyroid carcinoma. Here, CXCR4 is linked to differentiated thyroid carcinoma.